OncoLink Cancer Treatment and Resources

Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors



Joel W. Goldwein, MD
OncoLink co-Editor-In-Chief
Last Modified: October 24, 2000

Presenter: TE Merchant, MD
Affiliation: St. Jude Children's Research Hospital, Memphis, TN

Background:

Use of Conformal Radiation Therapy (CRT) for treatment of pediatric brain tumors has the potential for reducing toxicity and improving the therapeutic ratio.Ê The results of such treatment, and the relationships between dose, volume and CNS effects is largely unknown in this setting.Ê This report is of the St. Judes experience in treating children using this modality, with attention to local control and patterns of failure.


Materials and Methods:

  • 30 children with low grade astrocytoma (LGA) and 45 with ependymoma (12 malignant and 33 differentiated) were treated using CRT.

  • Margins were anatomically defined (CTV) extending 1.0 cm beyond the operative margin or residual tumor and a 0.5 cm margin (planning target volume) extending beyond the CTV.

  • LGA patients received a dose of 54 Gy in 1.8 Gy fractions, while ependymoma patients were treated to a dose of 59.4 Gy in 1.8 Gy fractions.


Results:

  • Median followup was 18.1 months for the LGA patients and 10.0 months for the ependymoma patients

  • 2 patients with LGA failed, 1 in the high dose region and one outside the high dose region

  • 2 patients with ependymoma failed.Ê Both had anaplastic lesions and both failed in the high dose volume

  • The failure rates were similar to those reported in other series of patients with LGA and ependymoma


Authors' Conclusions

  • Rates and patterns of failure for children with ependymoma and LGA treated with CRT volumes described above are similar to other reported series.


Clinical/Scientific Implications:

  • This is an intriguing report of CRT for pediatric brain tumors that suggests it is equal in efficacy to conventional RT.

  • Longer followup will be needed to assess late effects and true patterns of failure since patients with these tumors can relapse over relatively long periods

OncoLink I wish u knew...

Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS